|
In the world of concussion management, health care professionals from all aspects have focused on symptoms to evaluate and diagnose mTBI (concussions) and have essentially used those same symptoms to determine the treatment protocols and response to treatment as factors for return to activity. Neurological signs and symptoms are important factors in concussion management, but what interests Dr. Mike Alden and the doctors at Atlas Concussion even more is the cause of these signs and symptoms following a concussion. Dr. Alden has been using specific biomarkers that can objectively confirm the suspected diagnosis, previously based upon reported subjective symptoms and psychological testing conducted by athletic trainers, sports medicine physicians and neuropsychologists. The research that Dr. Alden bases his concussion management protocols on clearly proves that the signs and symptoms present after a head injury are caused by neurochemical components measurable with biomarkers exclusive to the Cyrex Lab’s Blood Brain Barrier Permeability Test.
The Atlas Concussion C1 Treatment ProtocolTM addresses these neurochemical components with strategies that are designed to reduce neuroinflammation, increase blood and oxygen flow to the injured sites, and help to close the blood brain barrier. Essentially, Dr. Alden has developed treatment strategies that are congruent with addressing the causes of the signs and symptoms that arise after a concussion has occurred, not merely focusing on those same subjective reports of symptoms. It’s no longer, “How are you feeling?”, but rather eliminating symptoms within 24-48 hours and then testing the blood to confirm that the blood brain barrier has healed. This combined innovative treatment and testing has elevated concussion management to new heights with Atlas Concussion Treatment and Testing. |
RSS Feed